Viewing nowCombinationSupria Tablet 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 201706344 · Approved 2017.07.31 · Insurance code 645604900
Improvement in blood pressure control for essential hypertension
This medication effectively helps patients with essential hypertension who have difficulty controlling blood pressure with either telmisartan or amlodipine monotherapy. In such cases, combining the two medications can lead to more stable blood pressure management. This contributes to preventing cardiovascular complications and improving the patient's health status. Therefore, it is used appropriately for blood pressure regulation in essential hypertension.
The recommended dosage for adults is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). - 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg.
Safety and efficacy have not been established for pediatric patients under 18 years of age, and administration of this medication is not recommended.
This medication can cause severe damage to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should not be used by pregnant women or those who may become pregnant. It is contraindicated in patients with certain conditions, such as severe hepatic impairment, severe hypotension, cardiogenic shock, and unstable heart failure following acute myocardial infarction. Particular caution is required when administering this medication to patients with impaired liver or kidney function, specific valvular heart diseases, or the elderly. During treatment, side effects such as dizziness or peripheral edema may commonly occur, and severe side effects can rare occur; therefore, patients should consult a doctor immediately if unusual symptoms arise. Regular monitoring of blood pressure, kidney function, and serum electrolyte levels is necessary, especially as there is a risk of hyperkalemia, requiring careful observation of potassium levels. Interactions may occur when taken with other antihypertensive medications or specific medicines, so patients should inform their doctor or pharmacist about any other medications they are taking. This medication is not recommended for breastfeeding women and should be avoided during lactation. Safety and efficacy have not been established for children, so its use is not advised. In the case of overdose, hypotension, dizziness, and heart-related problems may occur, so it is important to avoid exceeding the prescribed dose, and seek medical attention immediately if side effects are suspected. Store this medication out of reach of children, do not transfer to another container, and open the packaging just before taking.
Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory difficulties with cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, decreased urine output
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it should be kept at a normal room temperature between 1°C and 30°C, avoiding extreme heat or cold.
Biconvex oval double-coated tablets in white and light blue
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.